Jianzhong Zhang
Peking University People's Hospital · The Peking University People's Hospital · The Peking University People's Hospital, Beijing, Beijng
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Jianzhong Zhang as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:16 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT07838727 · A Phase 2 Study of MG-K10 in Chronic Spontaneous UrticariaShanghai Mabgeek Biotech.Co.Ltd · not yet recruiting · Chronic Urticaria, Idiopathic · principal investigator
- Ph1/Ph2NCT07828639 · A Study of VC005 Tablets in Adolescent Subjects With Non-Segmental VitiligoJiangsu vcare pharmaceutical technology co., LTD · not yet recruiting · Non-Segmental Vitiligo · principal investigator
- Ph1NCT07762443 · A Phase I Study of VC005 Tablets in Adolescent Subjects With Severe Alopecia AreataJiangsu vcare pharmaceutical technology co., LTD · recruiting · Alopecia Areata · principal investigator
- Ph2NCT07749716 · Phase II Clinical Study of VC005 Tablets in Subjects With Severe Alopecia AreataJiangsu vcare pharmaceutical technology co., LTD · recruiting · Alopecia Areata · principal investigator
- Ph3NCT07712731 · HPP737 in Adult Patients With Plaque PsoriasisNewsoara Biopharma Co., Ltd. · completed · Psoriasis · principal investigator
- Ph3NCT07712705 · HPP737 in Adult Patients With Moderate-to-severe Plaque Psoriasis.Newsoara Biopharma Co., Ltd. · completed · Psoriasis · principal investigator
- Ph3NCT07402213 · Trial of JYB1904 Injection in Adult Patients With Chronic Spontaneous Urticaria.Jemincare · recruiting · Chronic Spontaneous Urticaria · principal investigator
- Ph2NCT07230483 · A Long-term Safety and Efficacy Study Evaluating CM512 in Atopic Dermatitis.Keymed Biosciences Co.Ltd · recruiting · Atopic Dermatitis (AD) · principal investigator
- Ph3NCT07130604 · Evaluate the Efficacy and Safety of D-2570 in Subjects With Moderate to Severe Plaque PsoriasisInventisBio Co., Ltd · recruiting · Plaque Psoriasis · principal investigator
- Ph2NCT07076706 · Clinical Trial to Evaluate CG2001 in Chinese Adult Male Participants With Androgenetic AlopeciaBeijing Dayspring Pharmaceutical Technology Co., Ltd · completed · Male Pattern of Hair Loss, Androgenic Alopecia, Androgenetic Alopecia (AGA) · study chair
- Ph2NCT07054736 · Evaluate the Efficacy and Safety of XKH001 Injection in Patients With Moderate-to-Severe Atopic DermatitisZhejiang Kanova Biopharmaceutical Co., LTD · not yet recruiting · Atopic Dermatitis · principal investigator
- Ph1NCT07038941 · Phase I Clinical Trial of CG2001 in Chinese Adult Male Participants With Androgenetic AlopeciaBeijing Dayspring Pharmaceutical Technology Co., Ltd · completed · Male Pattern of Hair Loss, Androgenic Alopecia, Androgenetic Alopecia (AGA) · principal investigator
- Ph2NCT06947980 · Study of CM512 in Patients With Moderate-to-Severe Atopic DermatitisKeymed Biosciences Co.Ltd · recruiting · Atopic Dermatitis · principal investigator
- Ph3NCT06779136 · Phase III Clinical Study of MG-K10 Humanized Mab Injection in Subjects With Prurigo NodularisShanghai Mabgeek Biotech.Co.Ltd · recruiting · Prurigo Nodularis · study director
- Ph3NCT06495229 · Study of CM310 in Adolescent Subjects With Atopic DermatisKeymed Biosciences Co.Ltd · active not recruiting · Atopic Dermatitis · principal investigator
- Ph3NCT06477237 · Study of Efficacy and Safety of HB0017 in Patients With Moderate to Severe Plaque PsoriasisHuabo Biopharm Co., Ltd. · completed · Psoriasis · principal investigator
- Ph2/Ph3NCT06477536 · Long-Term Safety and Efficacy of HB0034 in Subjects With Generalized Pustular PsoriasisShanghai Huaota Biopharmaceutical Co., Ltd. · unknown · Generalized Pustular Psoriasis · principal investigator
- Ph3NCT06477835 · A Study to Evaluate the Efficacy and Safety of SIM0718 in Adult and Adolescent Patients With Moderate to Severe Atopic DermatitisSimcere Pharmaceutical Co., Ltd · completed · Atopic Dermatitis · principal investigator
- Ph2NCT06278350 · Evaluate the Efficacy and Safety of D-2570 in Participants With Moderate-to-Severe Plaque PsoriasisInventisBio Co., Ltd · completed · Plaque Psoriasis · principal investigator
- Ph3NCT06277765 · Study of CM310 Injection in Adolescent Subjects With Atopic DermatisKeymed Biosciences Co.Ltd · completed · Atopic Dermatitis · principal investigator
- Ph3NCT06277245 · A Phase 3 Study of LNK01001 Capsule in Subjects With Moderate to Severe Atopic Dermatitis.Lynk Pharmaceuticals Co., Ltd · completed · Atopic Dermatitis · principal investigator
- Ph1NCT06175143 · A Study to Evaluate the Safety and Efficacy of GR2002 Injection in Patients With Atopic Dermatitis.Genrix (Shanghai) Biopharmaceutical Co., Ltd. · unknown · Atopic Dermatitis · principal investigator
- Ph3NCT06126965 · Phase III Study of KX-826 With Adult Male Patients With AGASuzhou Kintor Pharmaceutical Inc, · unknown · Androgenetic Alopecia · principal investigator
- Ph2NCT06085521 · A Study of LNK01001 Capsule in Patients With Moderate to Severe Atopic DermatitisLynk Pharmaceuticals Co., Ltd · completed · Atopic Dermatitis · principal investigator
- Ph3NCT06026891 · Study of MG-K10 Humanized Monoclonal Antibody Injection in Patients With Atopic DermatitisShanghai Mabgeek Biotech.Co.Ltd · unknown · Atopic Dermatitis · principal investigator
- Ph2NCT05940506 · Phase II Study Evaluating the Efficacy and Safety of KX-826Suzhou Kintor Pharmaceutical Inc, · completed · Androgenetic Alopecia (AGA) · principal investigator
- Ph3NCT05667623 · To Demonstrate the Superiority of IMP (1% OPA-15406 Ointment) to the Vehicle in Adult Patients With ADOtsuka Beijing Research Institute · completed · Atopic Dermatitis (AD) · principal investigator
- Ph2NCT05531682 · A Study to Evaluate the Efficacy and Safety of HB0017 in Patients With Moderate to Severe Plaque PsoriasisHuabo Biopharm Co., Ltd. · completed · Plaque Psoriasis · principal investigator
- Ph3NCT05265923 · A Study of CM310 in Patients With Moderate-to-Severe Atopic DermatitisKeymed Biosciences Co.Ltd · completed · Atopic Dermatitis · principal investigator
- Ph3NCT05255237 · Extension Study to Evaluate Safety and Efficacy of Jaktinib in Adults With Alopecia AreataSuzhou Zelgen Biopharmaceuticals Co.,Ltd · completed · Alopecia Areata · principal investigator
- N/ANCT05023668 · China Atopic Dermatitis Registry StudyPeking University People's Hospital · unknown · Dermatitis, Atopic · principal investigator
- Ph3NCT04839328 · A Phase Ⅲ Efficacy and Safety Study of Hemay005 in Subjects With Moderate to Severe Plaque PsoriasisTianjin Hemay Pharmaceutical Co., Ltd · completed · Psoriasis · principal investigator
- Ph2NCT04173637 · Clinical Study of AK101 in Subjects With Moderate to Severe Plaque PsoriasisAkeso · completed · Plaque Psoriasis · principal investigator
- Ph3NCT03316781 · Study of Efficacy and Safety of HLX03 in Subjects With Moderate to Severe Plaque PsoriasisShanghai Henlius Biotech · completed · Plaque Psoriasis · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:16 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 10:16 UTC. The ranking covers the 200 most relevant of 4271 PubMed records, and a shared surname and initials can bring in a namesake. All 4271 on PubMed
- 163 citationsRCR 33.1
- 47 citationsRCR 7.3
- Adjuvant nivolumab versus placebo for high-risk muscle-invasive urothelial carcinoma: 5-year efficacy and ctDNA results from CheckMate 274.Ann Oncol · 202645 citationsRCR 22.5
- Final analysis of nivolumab plus cabozantinib for advanced renal cell carcinoma from the randomized phase III CheckMate 9ER trial.Ann Oncol · 202637 citationsRCR 18.5
- 31 citationsRCR 8.0
- Intensive vs Conventional Intraoperative Blood Pressure Management on Cardiovascular Events After Major Abdominal Surgery: The BP-CARES Randomized Trial.J Am Coll Cardiol · 202530 citationsRCR 13.9
- Ivarmacitinib for Moderate to Severe Atopic Dermatitis in Adults and Adolescents: A Phase 3 Randomized Clinical Trial.JAMA Dermatol · 202524 citationsRCR 7.3
- Probiotic-induced enrichment of Adlercreutzia equolifaciens increases gut microbiome wellness index and maps to lower host blood glucose levels.Gut Microbes · 202524 citationsRCR 7.4
- Lazertinib Versus Osimertinib in Previously Untreated EGFR-Mutant Advanced NSCLC: A Randomized, Double-Blind, Exploratory Analysis From MARIPOSA.J Thorac Oncol · 202522 citationsRCR 4.3
- 22 citationsRCR 11.0